Amneal Pharmaceuticals, Inc. (AMRX)
17.78
-0.13
(-0.73%)
USD |
NASDAQ |
Aug 24, 16:00
17.77
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Market Cap : 5.678B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.719B |
| August 20, 2026 | 5.716B |
| August 19, 2026 | 5.783B |
| August 18, 2026 | 5.809B |
| August 17, 2026 | 5.882B |
| August 14, 2026 | 5.796B |
| August 13, 2026 | 5.515B |
| August 12, 2026 | 5.639B |
| August 11, 2026 | 5.461B |
| August 10, 2026 | 5.710B |
| August 07, 2026 | 5.793B |
| August 06, 2026 | 5.770B |
| August 05, 2026 | 5.895B |
| August 04, 2026 | 5.901B |
| August 03, 2026 | 6.013B |
| July 31, 2026 | 5.844B |
| July 30, 2026 | 5.901B |
| July 29, 2026 | 6.093B |
| July 28, 2026 | 5.984B |
| July 27, 2026 | 5.771B |
| July 24, 2026 | 5.716B |
| July 23, 2026 | 5.732B |
| July 22, 2026 | 5.662B |
| July 21, 2026 | 5.774B |
| July 20, 2026 | 5.582B |
| Date | Value |
|---|---|
| July 17, 2026 | 5.694B |
| July 16, 2026 | 5.755B |
| July 15, 2026 | 5.487B |
| July 14, 2026 | 5.324B |
| July 13, 2026 | 5.480B |
| July 10, 2026 | 5.426B |
| July 09, 2026 | 5.429B |
| July 08, 2026 | 5.410B |
| July 07, 2026 | 5.439B |
| July 06, 2026 | 5.397B |
| July 02, 2026 | 5.471B |
| July 01, 2026 | 5.413B |
| June 30, 2026 | 5.522B |
| June 29, 2026 | 5.515B |
| June 26, 2026 | 5.496B |
| June 25, 2026 | 5.525B |
| June 24, 2026 | 5.509B |
| June 23, 2026 | 5.315B |
| June 22, 2026 | 5.139B |
| June 18, 2026 | 5.171B |
| June 17, 2026 | 5.193B |
| June 16, 2026 | 5.184B |
| June 15, 2026 | 5.181B |
| June 12, 2026 | 5.168B |
| June 11, 2026 | 5.212B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 6.261B |
| Eli Lilly & Co. | 1.175T |
| Indivior Pharmaceuticals, Inc. | 4.269B |
| Viatris, Inc. | 19.11B |
| Pfizer Inc. | 159.46B |
Market Cap Related Metrics
| PE Ratio | 37.10 |
| PS Ratio | 1.868 |
| PEG Ratio | 0.0050 |
| Price to Book Value | 171.92 |
| Price | 17.78 |
| Earnings Yield | 2.70% |
| PEGY Ratio | 0.0050 |
| Operating PE Ratio | 12.21 |
| Normalized PE Ratio | 28.62 |